Children's Hospital of Philadelphia
Blood & Marrow Transplant Program
3401 Civic Center Blvd
Philadelphia, PA 19104
Direct phone: (215) 590-2820
Total transplants by cell source
- Marrow: 32
- PBSC: 80
- Cord Blood: 4
- Autologous (PBSC or Marrow): 130
About the center
Our FACT-accredited program was established in 1986 and has been performing unrelated transplants since 1990. We have three Family House facilities nearby for use by our patients and their families. Our inpatient unit is HEPA filtered and caregivers can spend the night. Our team is dedicated to using an integrated family-centered approach to provide excellent patient care and innovative research opportunities.
This center has been performing allogeneic transplants since 1976 and has been an NMDP/Be The Match transplant center since February 1989.
Pediatric - David Barrett, Allison Barz Leahy, Nancy Bunin, Amanda DiNofia, Caitlin Elgarten, Jason Freedman, Stephan Grupp, Timothy Olson, Charles Phillips, Alix Seif, David Teachey, Lisa Wray
Marrow/PBSC and single cord
Cord blood transplants performed on
Other programs and services
Our center has multiple licensed social workers to assist with discharge planning and other needs of the patient. Our center has a licensed psychologist that works on our team directly with our patients and families to manage the complex needs the families will have during the transplant process.
Once discharged families are eligible to stay at the Philadelphia Ronald McDonald House on the dedicated Immunocompromised floor. There are eight suites with 2 bedrooms, living area, bathroom, a kitchenette and full sized refrigerator and microwave. There is a community Kitchen only to be used by families on the immunocompromised floor. Washers and dryers are only to be used by families on the immunocompromised floor. Patients and families have access to dedicated psychosocial support at the House.
Overall center survival
Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center.
The survival information we have for this center includes ONLY:
- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2017, 2018, 2019, and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 160 patients.
The actual 1-year survival of these patients is 84.1%.
Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 81.2% and 91.4%.
For help with understanding these statistics, please see Understanding Transplant Outcomes.
For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.
Transplants reported (From January 1, 2019 to December 31st, 2020 as reported by the centers)
|Both marrow & PBSC
Transplants by disease
Number of transplants by age reported from January 1, 2019 to December 31st, 2020 (includes marrow, PBSC and cord blood)
Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants for this disease can be found:
Transplant center resources
Transplant center coordinator:
Be The Match patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
Inside the United States: 1 (888) 999-6743
Outside the United States: 1 (763) 406-3410.
(Long distance or international charges may apply.)